These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6556018)

  • 1. The complement system in pregnancy.
    Adelsberg BR
    Am J Reprod Immunol (1980); 1983; 4(1):38-44. PubMed ID: 6556018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR; Forristal J; Beischel L
    J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proteases in complement system (author's transl)].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S; Tamura N; Fujita T
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of complement activity].
    Chenchikova EP
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):21-31. PubMed ID: 308752
    [No Abstract]   [Full Text] [Related]  

  • 6. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
    J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nephritic factor on C3 and on the terminal pathway of complement in vivo and in vitro.
    Mollnes TE; Ng YC; Peters DK; Lea T; Tschopp J; Harboe M
    Clin Exp Immunol; 1986 Jul; 65(1):73-9. PubMed ID: 3641694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between the alternative complement pathway and proteases of the coagulation system.
    Kazatchkine MD; Jouvin MH
    Adv Exp Med Biol; 1984; 167():235-9. PubMed ID: 6561912
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of Trypanosoma cruzi membrane components on the formation of the classical pathway C3 convertase.
    Kipnis TL; Tambourgi DV; Sucupira M; Dias-da-Silva W
    Braz J Med Biol Res; 1986; 19(2):271-8. PubMed ID: 3548858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies against components of the classical pathway of complement.
    Heinz HP; Loos M
    Complement Inflamm; 1989; 6(3):166-74. PubMed ID: 2472920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT; Cooper NR; Schreiber RD
    J Immunol; 1979 Jan; 122(1):34-8. PubMed ID: 762421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma lewisi: restriction of alternative complement pathway C3/C5 convertase activity.
    Sturtevant JE; Balber AE
    Exp Parasitol; 1987 Jun; 63(3):260-71. PubMed ID: 3556206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model system for the study of the assembly and regulation of human complement C3 convertase (classical pathway).
    Thielens NM; Colomb MG
    Eur J Immunol; 1986 Jun; 16(6):617-22. PubMed ID: 3487454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C142 complement activity and conglutinogen in bovine milk.
    De Cueninck BJ
    Int Arch Allergy Appl Immunol; 1979; 59(3):323-7. PubMed ID: 571843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of the C4 nephritic factor. Deregulation of the classical pathway of C3 convertase.
    Gigli I; Sorvillo J; Mecarelli-Halbwachs L; Leibowitch J
    J Exp Med; 1981 Jul; 154(1):1-12. PubMed ID: 7019379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
    Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
    Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
    Densen P; McRill CM; Ross SC
    J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.